Xenograft mouse model revealed that METTL1 overexpression significantly promoted the ESCC progression in vivo, as revealed by the increased tumor volumes/weights and upregulated Ki67 levels (Supplementary Fig. 12a–f). This evidence concerns the gene METTL1 and esophageal squamous cell carcinoma.